Physician

Oliver Chambers Songlingco, M.D.

According to 2025 Medicare claims, Oliver Songlingco, M.D. (NPI: 1891887964) practices nephrology in the Niles, MI market, with the plurality of this provider's patient population coming from Berrien, MI. This provider's primary affiliated billing organization is LAKE MICHIGAN NEPHROLOGY, L.L.C (NPI: 1821201500; TIN: 383572004) and primary practice location at 49085-8511.

Songlingco's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 345 traditional Medicare patients, billed 1,517 HCPCS/CPT codes, and received $145,341 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,771 prescription claims across 427 beneficiaries totaling $976,132 in drug costs, led by Jardiance (Empagliflozin). 2021 DME data shows 24 claims. Open Payments data shows 3 records totaling $51. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $302,964 to $976,132. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	588	1,871	$189,016
2016	441	1,484	$154,687
2017	443	1,593	$164,498
2018	493	1,684	$183,121
2019	595	1,961	$216,837
2020	569	2,164	$246,401
2021	505	1,677	$199,141
2022	435	1,445	$177,698
2023	385	1,277	$152,552
2024	345	1,517	$145,341

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	326	2,398	$302,964
2016	336	2,729	$366,588
2017	347	2,757	$499,779
2018	336	2,244	$186,061
2019	342	2,092	$148,024
2020	350	2,230	$180,450
2021	407	2,247	$173,332
2022	415	2,791	$273,331
2023	384	2,580	$485,993
2024	427	2,771	$976,132

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	25	$276
2021	N/R	24	$239
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	53	136	$285
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	53	55	$139
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	55	126	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	198	477	$89
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	194	450	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	188	11,794	$219,669
Farxiga	Dapagliflozin Propanediol	190	11,220	$202,343
Tavneos	Avacopan	12	360	$196,692
Kerendia	Finerenone	67	3,400	$68,088
Trulicity	Dulaglutide	23	700	$23,789

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$51	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Oliver Chambers Songlingco, M.D.?

Tedicare shows public-source Medicare data for Oliver Chambers Songlingco, M.D. (NPI 1891887964), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Oliver Chambers Songlingco, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Oliver Chambers Songlingco, M.D.?

Oliver Chambers Songlingco, M.D. is linked to LAKE MICHIGAN NEPHROLOGY, L.L.C (billing NPI 1821201500) in the available physician profile data.

Does Oliver Chambers Songlingco, M.D. have Open Payments data?

Oliver Chambers Songlingco, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.